ArticleInternational journal of clinical and health psychology : IJCHP
HD-tDCS over prefrontal cortex alleviates the inhibitory control and sleep problems of insomnia with objective short sleep duration.
Article in International journal of clinical and health psychology : IJCHP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insomnia disorder with objective short sleep duration (ISSD) is a severe phenotype associated with significant health risks including hypertension, diabetes, and cognitive impairment. It has been found that sleep problems in ISSD can be alleviated by improving inhibitory control (IC) ability. Therefore, there is a need to develop more effective interventions targeting inhibitory control to relief the symptom in ISSD. Objective: This study aimed to investigate whether high-definition transcranial direct current stimulation (HD-tDCS) targeting the right dorsolateral prefrontal cortex (dlPFC) could improve inhibitory control and sleep quality in ISSD. Methods: In a randomized, single-blind, sham-controlled trial, 50 ISSD were assigned to real (n = 25) or sham (n = 25) HD-tDCS groups (2 mA, 25 min/day for 7 days). Forty-one participants completed the study (real: 21, sham: 20). Primary outcomes were inhibitory control (accuracy of NoGO trial in Go/NoGo task, NoGo-ACC) and subjective sleep quality (Pittsburgh Sleep Quality Index; PSQI; Insomnia Severity Index, ISI). Secondary outcomes included objective sleep measures (total sleep time, sleep latency) collected via forehead EEG device. Results: After the intervention, participants who received HD-tDCS had significantly better response inhibition (NoGo-ACC) and sleep quality (ISI, PSQI, sleep latency subdimension of PSQI, and daytime functioning subdimension of PSQI) than the sham group. Conclusions: These findings establish right dlPFC-targeted HD-tDCS as a potentially safe and effective neuromodulatory approach for ISSD, though optimized protocols may be required for full clinical remission. Future studies should investigate combined interventions and include neurochemical assessments to elucidate underlying mechanisms. Trial registration: The study was prospectively registered on September 29, 2024, in Chinese Clinical Trials registry (ChiCTR2400090393).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.